Radioembolization is an established treatment for chemoresistant and unresectable liver
cancers. Currently, treatment planning is often based on semi-empirical methods, which …

Introduction: Outcomes in metastatic colorectal cancer are improving, with better
understanding and use of targeted therapies. Areas covered: A review of the literature and …

The treatment of malignancies has undergone dramatic changes in the past few decades.
Advances in drug delivery techniques and nanotechnology have allowed for new …

Background The primary tumor side is emerging as a major prognostic factor for patients
with metastatic colorectal cancer (mCRC). We examined the survival data from 2 …

Purpose This study aimed at identifying prior therapy dosimetric parameters using 99m Tc-
labeled macro-aggregates of albumin (MAA) that are associated with contralateral hepatic …

Purpose To identify clinical parameters that are prognostic for improved overall survival (OS)
after yttrium-90 radioembolization (RE) in patients with liver metastases from colorectal …

OBJECTIVE. The objective of this article is to discuss the current treatment options for
colorectal cancer (CRC) liver metastases and the role of ablation. CONCLUSION. A …

The technique of hepatic arterial infusion (HAI) for the treatment of liver metastases from
colorectal cancer has been developed over more than 30 years. Although the indications …

Purpose To determine the relationship between diffusion-weighted (DW) liver MR images
obtained 4–6 weeks after lobar yttrium 90 (90Y) treatment and overall survival in comparison …

Purpose To assess applicability of metabolic tumor response assessment on 18 F-
fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET)/computed tomography …